1. Genotyping and Drug Resistance Profile of Clinical Isolates of Candida albicans from Vulvovaginal Candidiasis in the Eastern China
- Author
-
Nan Hong, Rongfen Zhao, Nong Yu, Danyang Hu, Huan Chen, Wanqing Liao, Gang Wu, Shuwen Deng, Kin Ming Tsui, Liang Yan, Hong Zhang, Yan Lei, and Xiaofei Chen
- Subjects
Antifungal Agents ,Genotype ,Veterinary (miscellaneous) ,Microbial Sensitivity Tests ,Drug resistance ,Anidulafungin ,Applied Microbiology and Biotechnology ,Microbiology ,Drug Resistance, Fungal ,Candida albicans ,Humans ,Medicine ,Fluconazole ,Genotyping ,Candidiasis, Vulvovaginal ,Candida ,biology ,business.industry ,Eastern china ,biology.organism_classification ,Vulvovaginal Candidiasis ,Female ,Voriconazole ,business ,Agronomy and Crop Science - Abstract
A total of 244 Candida albicans isolates recovered from vulvovaginal candidiasis (VVC) patients in Suzhou, Eastern China, were investigated. According to CLSI documents M27-A4 and M59-3ed/M60-2ed, the MIC geometric means of nine antifungals in increasing order were micafungin (0.048 mg/L), anidulafungin (0.132 mg/L), caspofungin (0.19 mg/L), itraconazole (0.23 mg/L), posaconazole (0.25 mg/L), voriconazole (0.28 mg/L), 5-flucytosine (0.44 mg/L), amphotericin B (0.49 mg/L) and fluconazole (2.01 mg/L) respectively. Of note, 6.5% (16/244) C. albicans isolates showed resistance mainly to anidulafungin (mono-echinocandin resistance), while voriconazole had the lowest susceptibility rate of 34.8% (85/244), followed by fluconazole 59.4% (145/244), respectively. All isolates were genotyped by allelic combination of 3 microsatellite markers (CEF3, CAIII and LOC4). A total of 129 different allelic genotypes were identified, in which seven different clades were recognized with a discriminatory power of 0.96. Genotypes A-D were present in 35% of the isolates. In conclusion, decrease in antifungal drug susceptibility to C. albicans isolates from VVC is alarming. Our findings revealed the genetic diversity of C. albicans isolates among VVC patients and provided insights into the molecular epidemiology of Candida infections in China.
- Published
- 2022
- Full Text
- View/download PDF